Prosthetic Heart Valves
Overview :
- Mechanical valves are more durable than bioprosthetic valves but require lifelong anticoagulation
- Prosthetic valves in the aortic position are more durable and less prone to thromboembolism than valves in the mitral position.
Anticoagulation :
- Lifelong oral anticoagulation with warfarin is required for mechanical prosthesis. Target INRs are:
- 2.5 for an aortic prosthetic valve (bileaflet or current-generation single-tilting disc) without thromboembolism risk factors
- 3.0 for ball-in-cage aortic prosthetic valve with thromboembolism risk factors
- 3.0 for any mitral valve prosthesis
- AC Interruptions:
- Interrupt anticoagulation in patients with a prosthetic heart valve before noncardiac or dental surgery (but not cataract surgery).
- For aortic valve prostheses, stop warfarin 4 to 5 days before the procedure and restart as soon as postprocedure control of bleeding allows.
- In patients at high risk for thrombosis (mitral prostheses, multiple prosthetic valves, AF, or previous thromboembolic events), stop warfarin 4 to 5 days before surgery and begin bridging anticoagulation with IV heparin; resume IV heparin within 24 hours after surgery. Warfarin is also reinitiated after surgery, and heparin is discontinued when INR is therapeutic.
- Bioprosthetic heart valves DO NOT require long-term anticoagulation
Diagnostic Testing:
Treatment :
Prognosis:
References:
Created at: periodic/daily/August/2023-08-05-Saturday